153 related articles for article (PubMed ID: 30581047)
1. Tripeptide analogues of MG132 as protease inhibitors.
Pehere AD; Nguyen S; Garlick SK; Wilson DW; Hudson I; Sykes MJ; Morton JD; Abell AD
Bioorg Med Chem; 2019 Jan; 27(2):436-441. PubMed ID: 30581047
[TBL] [Abstract][Full Text] [Related]
2. New 26S proteasome inhibitors with high selectivity for chymotrypsin-like activity and p53-dependent cytotoxicity.
Neilsen PM; Pehere AD; Pishas KI; Callen DF; Abell AD
ACS Chem Biol; 2013 Feb; 8(2):353-9. PubMed ID: 23190346
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of peptidyl α,β-unsaturated carbonyl derivatives as anti-malarial calpain inhibitors.
Mallik SK; Li DY; Cui M; Song HO; Park H; Kim HS
Arch Pharm Res; 2012 Mar; 35(3):469-79. PubMed ID: 22477194
[TBL] [Abstract][Full Text] [Related]
4. Development of a Highly Selective Plasmodium falciparum Proteasome Inhibitor with Anti-malaria Activity in Humanized Mice.
Zhan W; Zhang H; Ginn J; Leung A; Liu YJ; Michino M; Toita A; Okamoto R; Wong TT; Imaeda T; Hara R; Yukawa T; Chelebieva S; Tumwebaze PK; Lafuente-Monasterio MJ; Martinez-Martinez MS; Vendome J; Beuming T; Sato K; Aso K; Rosenthal PJ; Cooper RA; Meinke PT; Nathan CF; Kirkman LA; Lin G
Angew Chem Int Ed Engl; 2021 Apr; 60(17):9279-9283. PubMed ID: 33433953
[TBL] [Abstract][Full Text] [Related]
5. Structure- and function-based design of Plasmodium-selective proteasome inhibitors.
Li H; O'Donoghue AJ; van der Linden WA; Xie SC; Yoo E; Foe IT; Tilley L; Craik CS; da Fonseca PC; Bogyo M
Nature; 2016 Feb; 530(7589):233-6. PubMed ID: 26863983
[TBL] [Abstract][Full Text] [Related]
6. Severe acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to proteasome-independent inhibition of M-calpain.
Schneider M; Ackermann K; Stuart M; Wex C; Protzer U; Schätzl HM; Gilch S
J Virol; 2012 Sep; 86(18):10112-22. PubMed ID: 22787216
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of non-peptidic cysteine protease inhibitors of P. falciparum derived from etacrynic acid.
Dude MA; Kaeppler U; Herb M; Schiller M; Schulz F; Vedder B; Heppner S; Pradel G; Gut J; Rosenthal PJ; Schirmeister T; Leippe M; Gelhaus C
Molecules; 2008 Dec; 14(1):19-35. PubMed ID: 19104483
[TBL] [Abstract][Full Text] [Related]
8. Covalent complexes of proteasome model with peptide aldehyde inhibitors MG132 and MG101: docking and molecular dynamics study.
Zhang S; Shi Y; Jin H; Liu Z; Zhang L; Zhang L
J Mol Model; 2009 Dec; 15(12):1481-90. PubMed ID: 19440739
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity-relationship studies of thiazolidinediones as antiplasmodial inhibitors of the Plasmodium falciparum cysteine protease falcipain-2.
Sharma RK; Younis Y; Mugumbate G; Njoroge M; Gut J; Rosenthal PJ; Chibale K
Eur J Med Chem; 2015 Jan; 90():507-18. PubMed ID: 25486422
[TBL] [Abstract][Full Text] [Related]
10. Pyrido[1,2-a]pyrimidin-4-ones as antiplasmodial falcipain-2 inhibitors.
Mane UR; Li H; Huang J; Gupta RC; Nadkarni SS; Giridhar R; Naik PP; Yadav MR
Bioorg Med Chem; 2012 Nov; 20(21):6296-304. PubMed ID: 23040894
[TBL] [Abstract][Full Text] [Related]
11. Rational Design of Proteasome Inhibitors as Antimalarial Drugs.
Le Chapelain C; Groll M
Angew Chem Int Ed Engl; 2016 May; 55(22):6370-2. PubMed ID: 27079849
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation, hydration site thermodynamics, and chemical reactivity analysis of α-keto substituted peptidomimetics for the inhibition of Plasmodium falciparum.
Weldon DJ; Shah F; Chittiboyina AG; Sheri A; Chada RR; Gut J; Rosenthal PJ; Shivakumar D; Sherman W; Desai P; Jung JC; Avery MA
Bioorg Med Chem Lett; 2014 Mar; 24(5):1274-9. PubMed ID: 24507921
[TBL] [Abstract][Full Text] [Related]
13. New tripeptide-based macrocyclic calpain inhibitors formed by N-alkylation of histidine.
Chen H; Jiao W; Jones MA; Coxon JM; Morton JD; Bickerstaffe R; Pehere AD; Zvarec O; Abell AD
Chem Biodivers; 2012 Nov; 9(11):2473-84. PubMed ID: 23161629
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles.
Tawa NE; Odessey R; Goldberg AL
J Clin Invest; 1997 Jul; 100(1):197-203. PubMed ID: 9202072
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of 3-methylene-substituted indolinones as antimalarials.
Praveen Kumar S; Gut J; Guedes RC; Rosenthal PJ; Santos MM; Moreira R
Eur J Med Chem; 2011 Mar; 46(3):927-33. PubMed ID: 21295887
[TBL] [Abstract][Full Text] [Related]
16. Falcipain-2 inhibition by suramin and suramin analogues.
Marques AF; Esser D; Rosenthal PJ; Kassack MU; Lima LM
Bioorg Med Chem; 2013 Jul; 21(13):3667-73. PubMed ID: 23680445
[TBL] [Abstract][Full Text] [Related]
17. Structure-Activity Relationship Studies of Antimalarial
Zhang H; Ginn J; Zhan W; Leung A; Liu YJ; Toita A; Okamoto R; Wong TT; Imaeda T; Hara R; Michino M; Yukawa T; Chelebieva S; Tumwebaze PK; Vendome J; Beuming T; Sato K; Aso K; Rosenthal PJ; Cooper RA; Liverton N; Foley M; Meinke PT; Nathan CF; Kirkman LA; Lin G
J Med Chem; 2023 Jan; 66(2):1484-1508. PubMed ID: 36630286
[TBL] [Abstract][Full Text] [Related]
18. Identification of potent and selective non-covalent inhibitors of the Plasmodium falciparum proteasome.
Li H; Tsu C; Blackburn C; Li G; Hales P; Dick L; Bogyo M
J Am Chem Soc; 2014 Oct; 136(39):13562-5. PubMed ID: 25226494
[TBL] [Abstract][Full Text] [Related]
19. Peptidomimetic nitrile inhibitors of malarial protease falcipain-2 with high selectivity against human cathepsins.
Nizi E; Sferrazza A; Fabbrini D; Nardi V; Andreini M; Graziani R; Gennari N; Bresciani A; Paonessa G; Harper S
Bioorg Med Chem Lett; 2018 May; 28(9):1540-1544. PubMed ID: 29615344
[TBL] [Abstract][Full Text] [Related]
20. Support vector machine based prediction of P. falciparum proteasome inhibitors and development of focused library by molecular docking.
Subramaniam S; Mehrotra M; Gupta D
Comb Chem High Throughput Screen; 2011 Dec; 14(10):898-907. PubMed ID: 21843142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
